 LOS ANGELES--BUSINESS WIRE--Puma Biotechnology, Inc. NASDAQ: PBYI, a biopharmaceutical company, announced that on April 12, 2021 the Compensation Committee of Pumas Board of Directors approved the grant of inducement restricted stock unit awards covering an aggregate of 36,500 shares of Puma common stock to six new non-executive employees. The award was granted under Pumas 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of 